1. Home
  2. CGEM vs SKYT Comparison

CGEM vs SKYT Comparison

Compare CGEM & SKYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • SKYT
  • Stock Information
  • Founded
  • CGEM 2016
  • SKYT 1991
  • Country
  • CGEM United States
  • SKYT United States
  • Employees
  • CGEM N/A
  • SKYT N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • SKYT Semiconductors
  • Sector
  • CGEM Health Care
  • SKYT Technology
  • Exchange
  • CGEM Nasdaq
  • SKYT Nasdaq
  • Market Cap
  • CGEM 530.0M
  • SKYT 427.5M
  • IPO Year
  • CGEM 2021
  • SKYT 2021
  • Fundamental
  • Price
  • CGEM $7.67
  • SKYT $8.85
  • Analyst Decision
  • CGEM Strong Buy
  • SKYT Strong Buy
  • Analyst Count
  • CGEM 5
  • SKYT 2
  • Target Price
  • CGEM $30.00
  • SKYT $11.50
  • AVG Volume (30 Days)
  • CGEM 348.1K
  • SKYT 714.9K
  • Earning Date
  • CGEM 08-07-2025
  • SKYT 08-06-2025
  • Dividend Yield
  • CGEM N/A
  • SKYT N/A
  • EPS Growth
  • CGEM N/A
  • SKYT N/A
  • EPS
  • CGEM N/A
  • SKYT N/A
  • Revenue
  • CGEM N/A
  • SKYT $323,929,000.00
  • Revenue This Year
  • CGEM N/A
  • SKYT N/A
  • Revenue Next Year
  • CGEM N/A
  • SKYT $22.00
  • P/E Ratio
  • CGEM N/A
  • SKYT N/A
  • Revenue Growth
  • CGEM N/A
  • SKYT 7.90
  • 52 Week Low
  • CGEM $6.85
  • SKYT $5.63
  • 52 Week High
  • CGEM $21.01
  • SKYT $19.00
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 38.41
  • SKYT 52.76
  • Support Level
  • CGEM $8.47
  • SKYT $8.18
  • Resistance Level
  • CGEM $9.25
  • SKYT $8.75
  • Average True Range (ATR)
  • CGEM 0.45
  • SKYT 0.43
  • MACD
  • CGEM -0.12
  • SKYT -0.10
  • Stochastic Oscillator
  • CGEM 5.06
  • SKYT 47.52

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About SKYT SkyWater Technology Inc.

SkyWater Technology Inc is a U.S.-based, independent, pure-play technology foundry that offers semiconductor development and manufacturing services from its fabrication facilities. In its technology as a service model, it leverages a foundation of proprietary technology, engineering to co-develop process technology intellectual property (IP) with its customers that enable disruptive concepts through its Technology Services for diverse microelectronics (integrated circuits) and related micro- and nanotechnology applications. It focuses on serving diversified, high-growth, end users in numerous vertical markets, including computation, aerospace and defense (A&D), automotive and transportation, bio-health, and industrial.

Share on Social Networks: